150 related articles for article (PubMed ID: 33371249)
1. Effects of Modification of Light Parameters on the Production of Cryptophycin, Cyanotoxin with Potent Anticancer Activity, in
Polyzois A; Kirilovsky D; Dufat TH; Michel S
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33371249
[TBL] [Abstract][Full Text] [Related]
2. Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from cyanobionts.
Magarvey NA; Beck ZQ; Golakoti T; Ding Y; Huber U; Hemscheidt TK; Abelson D; Moore RE; Sherman DH
ACS Chem Biol; 2006 Dec; 1(12):766-79. PubMed ID: 17240975
[TBL] [Abstract][Full Text] [Related]
3. The 6th Iberian and 2nd Ibero-American Cyanotoxin Congress CIC2019.
Aboal M
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33669571
[TBL] [Abstract][Full Text] [Related]
4. Effect of Light Intensity and Photoperiod on Growth and Biochemical Composition of a Local Isolate of Nostoc calcicola.
Khajepour F; Hosseini SA; Ghorbani Nasrabadi R; Markou G
Appl Biochem Biotechnol; 2015 Aug; 176(8):2279-89. PubMed ID: 26100389
[TBL] [Abstract][Full Text] [Related]
5. A convergent synthesis of (+)-cryptophycin B, a potent antitumor macrolide from Nostoc sp. cyanobacteria.
Ghosh AK; Bischoff A
Org Lett; 2000 Jun; 2(11):1573-5. PubMed ID: 10841482
[TBL] [Abstract][Full Text] [Related]
6. Cyclic peptides and depsipeptides from cyanobacteria: a review.
Moore RE
J Ind Microbiol; 1996 Feb; 16(2):134-43. PubMed ID: 8730577
[TBL] [Abstract][Full Text] [Related]
7. Toxicology of microcystins with reference to cases of human intoxications and epidemiological investigations of exposures to cyanobacteria and cyanotoxins.
Svirčev Z; Drobac D; Tokodi N; Mijović B; Codd GA; Meriluoto J
Arch Toxicol; 2017 Feb; 91(2):621-650. PubMed ID: 28042640
[TBL] [Abstract][Full Text] [Related]
8. Health-based cyanotoxin guideline values allow for cyanotoxin-based monitoring and efficient public health response to cyanobacterial blooms.
Farrer D; Counter M; Hillwig R; Cude C
Toxins (Basel); 2015 Feb; 7(2):457-77. PubMed ID: 25664510
[TBL] [Abstract][Full Text] [Related]
9. Impacts of varying light regimes on phycobiliproteins of Nostoc sp. HKAR-2 and Nostoc sp. HKAR-11 isolated from diverse habitats.
Kannaujiya VK; Sinha RP
Protoplasma; 2015 Nov; 252(6):1551-61. PubMed ID: 25772678
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of cyanobacteria and their toxins.
Pilotto LS
Adv Exp Med Biol; 2008; 619():639-49. PubMed ID: 18461787
[No Abstract] [Full Text] [Related]
11. Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity.
Ding Y; Seufert WH; Beck ZQ; Sherman DH
J Am Chem Soc; 2008 Apr; 130(16):5492-8. PubMed ID: 18366166
[TBL] [Abstract][Full Text] [Related]
12. Portoamides A and B are mitochondrial toxins and induce cytotoxicity on the proliferative cell layer of in vitro microtumours.
Sousa ML; Ribeiro T; Vasconcelos V; Linder S; Urbatzka R
Toxicon; 2020 Feb; 175():49-56. PubMed ID: 31887317
[TBL] [Abstract][Full Text] [Related]
13. Three new cryptophycins from Nostoc sp. GSV 224.
Subbaraju GV; Golakoti T; Patterson GM; Moore RE
J Nat Prod; 1997 Mar; 60(3):302-5. PubMed ID: 9090872
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effects of cylindrospermopsin in mitotic and non-mitotic Vicia faba cells.
Garda T; Riba M; Vasas G; Beyer D; M-Hamvas M; Hajdu G; Tándor I; Máthé C
Chemosphere; 2015 Feb; 120():145-53. PubMed ID: 25016338
[TBL] [Abstract][Full Text] [Related]
15. Isolation and structure determination of cryptophycins 38, 326, and 327 from the terrestrial cyanobacterium Nostoc sp. GSV 224.
Chaganty S; Golakoti T; Heltzel C; Moore RE; Yoshida WY
J Nat Prod; 2004 Aug; 67(8):1403-6. PubMed ID: 15332864
[TBL] [Abstract][Full Text] [Related]
16. Pathological modifications following sub-chronic exposure of medaka fish (Oryzias latipes) to microcystin-LR.
Trinchet I; Djediat C; Huet H; Dao SP; Edery M
Reprod Toxicol; 2011 Nov; 32(3):329-40. PubMed ID: 21839164
[TBL] [Abstract][Full Text] [Related]
17. A review on cylindrospermopsin: the global occurrence, detection, toxicity and degradation of a potent cyanotoxin.
de la Cruz AA; Hiskia A; Kaloudis T; Chernoff N; Hill D; Antoniou MG; He X; Loftin K; O'Shea K; Zhao C; Pelaez M; Han C; Lynch TJ; Dionysiou DD
Environ Sci Process Impacts; 2013 Oct; 15(11):1979-2003. PubMed ID: 24056894
[TBL] [Abstract][Full Text] [Related]
18. Effective doses, guidelines & regulations.
Burch MD
Adv Exp Med Biol; 2008; 619():831-53. PubMed ID: 18461792
[TBL] [Abstract][Full Text] [Related]
19. Risk Assessment Workgroup report.
Donohue J; Orme-Zavaleta J; Burch M; Dietrich D; Hawkins B; Lloyd T; Munns W; Steevens J; Steffensen D; Stone D; Tango P
Adv Exp Med Biol; 2008; 619():759-829. PubMed ID: 18461791
[TBL] [Abstract][Full Text] [Related]
20. Editorial (Thematic Issue: Cellular and Biochemical Effects of Microcystins (Cyanobacterial Toxins) and Their Potential Medical Consequences).
Máthé C
Mini Rev Med Chem; 2016; 16(13):1017. PubMed ID: 27553061
[No Abstract] [Full Text] [Related]
[Next] [New Search]
